Literature DB >> 12609543

Characterization of an interleukin-7-dependent thymic cell line derived from a p53(-/-) mouse.

Kyungjae Kim1, Annette R Khaled, Della Reynolds, Howard A Young, Chong-Kil Lee, Scott K Durum.   

Abstract

In order to study the response of T cells to IL-7, we aimed to generate an IL-7-dependent thymocyte line. CD4(-)CD8(-) thymocytes from a p53(-)/(-) mouse were continuously propagated in interleukin-7 (IL-7), and after 2 months there developed an immortal line termed "D1." The D1 line has retained a stable dependency on IL-7. Withdrawal of IL-7 from D1 cells induced arrest in G1 phase of the cell cycle, followed by apoptosis. In addition to IL-7, several other cytokines that employ gamma(c) as part of their receptor were also capable of stimulating D1 cell survival and proliferation. Gene induction by IL-7 was analyzed in D1 cells using RNase protection and array analysis and revealed a number of transcripts potentially involved in cell cycle, apoptosis and signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12609543     DOI: 10.1016/s0022-1759(02)00513-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  25 in total

1.  Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells.

Authors:  Roberta Zappacosta; Francesca B Aiello; Tommaso D'Antuono; Antonio D Procopio; Scott K Durum; Pio Conti; Sandra Rosini
Journal:  Ann Clin Lab Sci       Date:  2011       Impact factor: 1.256

2.  The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Authors:  Shannon M Ruppert; Wenqing Li; Ge Zhang; Adina L Carlson; Arati Limaye; Scott K Durum; Annette R Khaled
Journal:  Biochim Biophys Acta       Date:  2012-06-21

3.  IL-7Rα deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis.

Authors:  R Kibe; S Zhang; D Guo; L Marrero; F Tsien; P Rodriguez; S Khan; A Zieske; J Huang; W Li; S K Durum; T Iwakuma; Y Cui
Journal:  Cell Death Differ       Date:  2012-01-27       Impact factor: 15.828

4.  Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology.

Authors:  Annette Khaled; Songchuan Guo; Feng Li; Peixuan Guo
Journal:  Nano Lett       Date:  2005-09       Impact factor: 11.189

5.  Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.

Authors:  Songchuan Guo; Nuska Tschammer; Sulma Mohammed; Peixuan Guo
Journal:  Hum Gene Ther       Date:  2005-09       Impact factor: 5.695

6.  Efflux Transporters Regulate Arsenite-Induced Genotoxicity in Double Negative and Double Positive T Cells.

Authors:  Huan Xu; Sebastian Medina; Fredine T Lauer; Christelle Douillet; Ke Jian Liu; Laurie G Hudson; Miroslav Stýblo; Lauren M Aleksunes; Scott W Burchiel
Journal:  Toxicol Sci       Date:  2017-07-01       Impact factor: 4.849

7.  The interaction of LCK and the CD4 co-receptor alters the dose response of T-cells to interleukin-7.

Authors:  Christina Kittipatarin; Nuska Tschammer; Annette R Khaled
Journal:  Immunol Lett       Date:  2010-04-28       Impact factor: 3.685

Review 8.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

9.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

10.  Interleukin-7 regulates Bim proapoptotic activity in peripheral T-cell survival.

Authors:  Wen Qing Li; Tad Guszczynski; Julie A Hixon; Scott K Durum
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.